Neutrophil Serine Proteases Are Most Probably Involved in the Release of CD43 (leukosialin, sialophorin) From the Neutrophil Membrane During Cell Activation
To the Editor:
extent, to cathepsin G by a mechanism that does not require a previous desialylation of the CD43 molecule. When analyzing the similarIn the September 15, 1995 issue of Blood, Remold-O'Donnel et ities between the cleavage of CD43 by exogeneous elastase and al' report on the cleavage of neutrophil CD43 by neutrophil elastase.
the proteolytic release of the molecule observed during neutrophil This confirms previous works, including
showing that neutroactivation, we observed the following points: phi1 CD43 is resistant to serine proteases such as trypsin or chymo- agonist. During PMN activation by FMLP in the presence of cytochalasin B, the cleavage of CD43 is blocked by all serine-protease inhibitors tested, including DFP, phenylmethylsulfonyl fluoride (PMSF). eglin C (Fig IA) , pefabloc SC, or SBTI (data not shown). This appears also to be the case of the release of CD43 triggered by tumor necrosis factor-a (TNF-CY) and adherence' or the "spontaneous" shedding of CD43 described by Remold-O'Donnell and Parent4 By contrast, confirming previous report^,'.^ we observed that the release of CD43 induced by phorbol myristate acetate (PMA) activation is not inhibited by DFP, SBTI. or eglin C, while efficiently blocked by PMSF or pefabloc SC (Fig IA and data not shown) .
(2) Similar 55,000 and 47.000 Mr CD43 soluble fragments. or 155,OOO and 95,000 Mr asialofragments, are immunoprecipitated from supernatants of PMA-or FMLP and cytochalasin B-activated cell and of elastase-treated cells (Fig IB) . The 120.000 Mr fragment released during cell activation'.'" is not observed with exogeneous elastase. However, this does not exclude that this large fragment is released by an endogeneous elastase-like enzyme, either membranebound or released at the membrane level, which, unlike the exogen-eous enzyme, would have access to a CD43 proteolytic cleavage site close to the membrane.
Remold-O'Donnell and Parent proposed two different pathways of CD43 cleavage": a "spontaneous" cleavage mediated by an elastase-like enzyme resulting in the release of 55.000 and 47,000 fragments and another pathway involving an unknown non serine-protease "CD43'ase" activated by PMA. Although no soluble CD43 fragment specifically released by PMA could be identified, this hypothesis was based on the observation that PMA decreases cell labeling by the T30S monoclonal antibody (MoAb) which recognizes the residual cell-associated CD43 fragment after cell treatment with elastase. However, we would like to point out that the PMA-induced CD43 cleavage was inhibited by PMSF and pefabloc SC, which are serine protease inhibitors. Furthermore, we always immunoprecipitated similar proportions of the various CD43 fragments, whether cells were activated by PMA or by cytochalasin B and FMLP. suggesting that the same elastase-like and/or putative CD43'ase are involved in all situations. In our hands, if cells are isolated by "nonactivating" cell isolation procedures and incubated at physiological concentrations, no "spontaneous" release of CD43 is observed in the absence of activators.' Alternative hypotheses to explain the different susceptibilities of CD43 release to protease inhibitors may be proposed: ( I ) PMA and FMLP or TNF may release and/or activate different serine-proteases, more or less accessible to inhibitors such as DFP or the macromolecular eglin C. (2) PMA activation, but not FMLP or TNF, would modify CD43, possibly through an hyperphosphorylation of the molecule. and alter its T305 epitope as well as its susceptibility to proteases. allowing it to be cleaved by very low concentrations of an elastase-like enzyme at the membrane level, even in the presence of some inhibitors. Furthermore, with regard to possible functional relevance of CD43 shedding. we observed the following: ( I ) that elastase treatment does not by itself induce homotypic neutrophil aggregation. measured in stirred conditions by flow cytometry. This suggests that elastase not only removes CD43 but possibly also degrades adhesion molecules andor that homotypic adhesion requires the activation of adhesion receptors such as integrins as well as the shedding of repulsive molecules: (2) that elastase inhibitors PMSF and eglin C prevent TNFe or PMA-induced cell adhesion to proteincoated plates, further suggesting that the release of CD43 is required for cell adhesion. 
